Multimodal Large Language Models (MLLMs) have demonstrated impressive abilities across various tasks, including visual question answering and chart comprehension, yet existing benchmarks for chart-related tasks fall short in capturing the complexity of real-world multi-chart scenarios. Current benchmarks primarily focus on single-chart tasks, neglecting the multi-hop reasoning required to extract and integrate information from multiple charts, which is essential in practical applications. To fill this gap, we introduce MultiChartQA, a benchmark that evaluates MLLMs’ capabilities in four key areas: direct question answering, parallel question answering, comparative reasoning, and sequential reasoning. Our evaluation of a wide range of MLLMs reveals significant performance gaps compared to humans. These results highlight the challenges in multi-chart comprehension and the potential of MultiChartQA to drive advancements in this field. Our code and data are available at https://github.com/Zivenzhu/Multi-chart-QA.

Large pre-trained language models (PLMs) such as GPT-3 have shown strong in-context learning capabilities, which are highly appealing for domains such as biomedicine that feature high and diverse demands of language technologies but also high data annotation costs. In this paper, we present the first systematic and comprehensive study to compare the few-shot performance of GPT-3 in-context learning with fine-tuning smaller (i.e., BERT-sized) PLMs on two representative biomedical information extraction (IE) tasks: named entity recognition and relation extraction. We follow the true few-shot setting to avoid overestimating models’ few-shot performance by model selection over a large validation set. We also optimize GPT-3’s performance with known techniques such as contextual calibration and dynamic in-context example retrieval. However, our results show that GPT-3 still significantly underperforms compared to simply fine-tuning a smaller PLM. In addition, GPT-3 in-context learning also yields smaller gains in accuracy when more training data becomes available. More in-depth analyses further reveal issues of in-context learning that may be detrimental to IE tasks in general. Given the high cost of experimenting with GPT-3, we hope our study provides helpful guidance for biomedical researchers and practitioners towards more practical solutions such as fine-tuning small PLMs before better in-context learning is available for biomedical IE.